Non-Viral COVID-19 Nasal Vaccine Candidate Effective at Preventing Disease Transmission

Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says

Pfizer Prepares To Seek U.S., EU Approval After Study Shows Vaccine Is Safe For Five To 11-Year-Olds

F.D.A. Decision on Covid Booster Shots Is Expected In Days